In conclusion, the number of cells with a stem-like phenotype in retinoblastoma cell lines was increased by treatment with LiCl and by reducing the expression of the canonical Wnt pathway inhibitor SFRP2. This evidence concerns the gene SFRP2 and retinoblastoma.